Patent details
EP3059245
Title:
ACTRII RECEPTOR ANTAGONISTIC ANTIBODIES
Basic Information
- Publication number:
- EP3059245
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP151960713
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ACTRII RECEPTOR ANTAGONISTIC ANTIBODIES
- French Title of Invention:
- ANTICORPS ANTAGONISTES DU RÉCEPTEUR ACTRII
- German Title of Invention:
- ACTRII-REZEPTOR ANTAGONISTISCHE ANTIKÖRPER
- SPC Number:
-
Dates
- Filing date:
- 25/07/2005
- Grant date:
- 07/11/2018
- EP Publication Date:
- 24/08/2016
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/11/2018
- EP B1 Publication Date:
- 07/11/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 25/07/2025
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 31/10/2018
-
-
- Name:
- Acceleron Pharma Inc.
- Address:
- 128 Sidney Street, Cambridge, MA 02139, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 21/11/2018
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- KNOPF, John
- Address:
- United States (US)
2
- Name:
- SEEHRA, Jasbir
- Address:
- United States (US)
Priority
- Priority Number:
- 590765 P
- Priority Date:
- 23/07/2004
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 9/20;
A61K 38/17;
C07K 14/705;
Publication
European Patent Bulletin
- Issue number:
- 201845
- Publication date:
- 07/11/2018
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 14/06/2024
- Last Annual Fee Paid Number:
- 20
- Last Annual Fee Paid Amount:
- 300 Euro
- Payer:
- MASTER DATA CENTER INC (ex Clarivate Analytics)